Petros Pharmaceuticals, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Petros Pharmaceuticals, Inc. (PTPI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.62 billion shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 144.78M shares, a 2297.49% increase year-over-year.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 131.18M shares, a 1316.97% increase year-over-year.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 131.18M shares, a 30437.91% increase year-over-year.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.04M shares, a 1206.96% increase year-over-year.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 131.17M shares, a 38357.74% increase from fiscal 2024.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 341.08K shares, a 97.68% decline from fiscal 2023.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.70M shares, a 1232.08% increase from fiscal 2022.
- Petros Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.10M shares, a 2.42% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.62B shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 144.78M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 131.17M shares 10-K · filed 2026-04-15 | |||||||
| 2025-09-30 | 131.18M shares 10-Q · filed 2025-11-13 | 131.18M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 131.18M shares 10-Q · filed 2025-08-14 | 131.18M shares 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | 6.04M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 341.08K shares 10-K · filed 2026-04-15 | 8.53M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 9.26M shares 10-Q · filed 2025-11-13 | 9.26M shares 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 429.58K shares 10-Q · filed 2025-08-14 | 10.74M shares 10-Q · filed 2024-08-14 | 429.58K shares 10-Q · filed 2025-08-14 | 10.74M shares 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | 462.07K shares 10-Q · filed 2025-05-15 | 11.55M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 14.70M shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 15.18M shares 10-Q · filed 2024-11-13 | 15.18M shares 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | 1.21M shares 10-Q · filed 2024-08-14 | 1.21M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 1.09M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 1.10M shares 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | 1.11M shares 10-Q · filed 2023-11-15 | 10.63M shares 10-Q · filed 2022-11-14 | 1.11M shares 10-Q · filed 2023-11-15 | 10.63M shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 1.11M shares 10-Q · filed 2023-08-14 | 10.63M shares 10-Q · filed 2022-08-12 | 1.11M shares 10-Q · filed 2023-08-14 | 10.63M shares 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | 1.08M shares 10-Q · filed 2023-05-15 | 10.82M shares 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | 1.08M shares 10-K · filed 2023-03-31 | 10.77M shares 10-K · filed 2022-03-31 | ||||||
| 2021-09-30 | 5.62M shares 10-Q/A · filed 2022-11-15 | 5.62M shares 10-Q · filed 2021-11-15 | 5.62M shares 10-Q/A · filed 2022-11-15 | 5.62M shares 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | 5.62M shares 10-Q · filed 2022-08-12 | 5.62M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 5.20M shares 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 4.98M shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 21.14K shares 10-Q · filed 2021-11-15 | 21.14K shares 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | 127.40K shares 10-Q · filed 2021-08-16 | 127.40K shares 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | 127.40K shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |